Abstract

The pharmacology of antigen-induced early and late phase airway responses and the associated antigen-induced airway hyperresponsiveness was studied in allergic sheep. Data from studies with anti-allergic agents and specific receptor antagonists, especially leukotriene antagonists and antagonists of platelet activating factor (PAF), have led to the hypothesis that allergen-induced late responses in allergic sheep are linked to a heightened metabolism of arachidonic acid via the 5-lipoxygenase pathway. This increases leukotriene production during the acute allergic reaction, which results in a more prolonged acute bronchoconstriction and subsequently a more severe airway inflammation. These recruited inflammatory cells can then release mediators and other cell products which contribute to the late response and airway hyperresponsiveness.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call